首页> 外文期刊>Journal of nanoparticle research: An interdisciplinary forum for nanoscale science and technology >Cytotoxicity of pristine and functionalized tungsten disulfide particles in the urinary system
【24h】

Cytotoxicity of pristine and functionalized tungsten disulfide particles in the urinary system

机译:Cytotoxicity of pristine and functionalized tungsten disulfide particles in the urinary system

获取原文
获取原文并翻译 | 示例
       

摘要

Tungsten disulfide (WS2) particles have excellent lubrication properties and low surface energy. These features are exploited for numerous applications in the biomedical field, from the development of low-friction orthodontic wires to urinary encrustation-resisting coatings. Nevertheless, the cytotoxicity of spherical WS(2)particles still remains unclear. We report the biocompatibility of pristine WS(2)particles in human urinary bladder cells after the exposure to a wide range of concentrations (from 0 to 100 mu g/mL). Based on the cell viability assessments using trypan blue exclusion assay and the PrestoBlue Cell viability reagent after 24, 48, and 72 h exposure, it can be concluded that these particle aggregates, with a diameter of similar to 500 nm, do not show any evidence of alterations or toxicity in the cells, even with high concentrations there exist a 87 of cell viability. Furthermore, due to the predisposition to agglomerate of this material and the possible use as a coating in urinary devices, we functionalized these particles with carboxylic groups. Aggregates with a diameter of similar to 370 nm were obtained. Zeta potential measurements highlighted that carboxylation correctly occurred, showing a switch from similar to + 4 for pristine particles to similar to - 35 for COOH-functionalized ones. Cytotoxic studies with these functionalized WS(2)particles also showed good biocompatibility on human urinary bladder cells, with an 86 of viability after incubation with 100 mu g/mL of particles over 72 h. These results highlight a good potential of WS(2)particles for a future safe application as components of implantable medical devices.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号